Phase 1 Clinical Trial Met All Primary and Secondary Endpoints and Demonstrated Positive Safety, Pharmacokinetics, and ...

Zoliflodacin is an oral spiropyrimidinetrione antibiotic with activity against multidrug-resistant strains of Neisseria gonorrhoeae.

Dyne’s exon-skipping therapy zeleciment rostudirsen resulted in an approximately sevenfold increase in dystrophin levels at ...

Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, ...

A vial of the measles, mumps and rubella vaccine is on display at the Lubbock Health Department on Feb. 26, 2025, in Lubbock, ...

Texas Facility Expansion Increases Magnet Capacity, Supports Domestic Critical-Minerals Supply Chains and Increases Post-Tax NPV to US$780 million (forecast prices) and US$409 million (current prices) ...

The FDA has cleared the use of GSK’s Blujepa for the treatment of uncomplicated urogenital gonorrhea, unlocking the first new ...

FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against ...

The release of Phase III Stage 1 data for gotistobart (BNT316/ONC-392) at NACLC 2025 marks one of the most significant ...

Igyxos Biotherapeutics is dedicated to developing innovative treatments for infertility in both men and women. Its lead asset, IGX12, is a first-in-class potentiating monoclonal antibody designed to ...

Child care centers that also served infants and toddlers became harder to keep open when 4-year-olds went to transitional ...